View in EDS HTML Full Text PDF Full Text

Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.

Saved in:
Bibliographic Details
Title: Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.
Authors: Shorr, Andrew F.1 (AUTHOR), Jones, Mark E.2 (AUTHOR), Friedmann, Silke2 (AUTHOR), Ionescu, Daniel2 (AUTHOR), Saulay, Mikael2 (AUTHOR), Smart, Jennifer I.2 (AUTHOR), Engelhardt, Marc2 (AUTHOR) Marc.engelhardt@basilea.com
Source: PLoS ONE. 6/24/2025, Vol. 20 Issue 6, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 186139535
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Shorr%2C+Andrew+F%2E%22">Shorr, Andrew F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jones%2C+Mark+E%2E%22">Jones, Mark E.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Friedmann%2C+Silke%22">Friedmann, Silke</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ionescu%2C+Daniel%22">Ionescu, Daniel</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saulay%2C+Mikael%22">Saulay, Mikael</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Smart%2C+Jennifer+I%2E%22">Smart, Jennifer I.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Engelhardt%2C+Marc%22">Engelhardt, Marc</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> Marc.engelhardt@basilea.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 6/24/2025, Vol. 20 Issue 6, p1-12. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=186139535
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0326758
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shorr, Andrew F.
      – PersonEntity:
          Name:
            NameFull: Jones, Mark E.
      – PersonEntity:
          Name:
            NameFull: Friedmann, Silke
      – PersonEntity:
          Name:
            NameFull: Ionescu, Daniel
      – PersonEntity:
          Name:
            NameFull: Saulay, Mikael
      – PersonEntity:
          Name:
            NameFull: Smart, Jennifer I.
      – PersonEntity:
          Name:
            NameFull: Engelhardt, Marc
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 06
              Text: 6/24/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 19326203
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: PLoS ONE
              Type: main
ResultId 1